ProShares UltraShort Nasdaq Biotechnology

An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.

BIS trades at 19.03 USD today, its price has fallen −0.22% in the past 24 hours. Track more dynamics on BIS price chart.

BIS net asset value is 19.06 today — it's fallen 9.54% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.

BIS assets under management is ‪2.86 M‬ USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.

BIS price has risen by 0.16% over the last month, and its yearly performance shows a 9.02% increase. See more dynamics on BIS price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −9.54% over the last month, have fallen by −9.54% over the last month, showed a 19.56% increase in three-month performance and has increased by 13.80% in a year.

BIS fund flows account for ‪−430.35 K‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.

BIS invests in cash. See more details in our Analysis section.

BIS is an inverse fund, meaning it's structured to generate returns opposite to the trends of the underlying index or assets.

In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, BIS technical analysis shows the sell rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating BIS shows the buy signal. See more of BIS technicals for a more comprehensive analysis.

Yes, BIS pays dividends to its holders with the dividend yield of 3.44%.

BIS trades at a premium (0.08%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.

BIS shares are issued by ProShare Advisors LLC

BIS follows the NASDAQ / Biotechnology. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

The fund started trading on Apr 7, 2010.